Return to Listing

1 result(s) for

PI Name Protocol # Title
Joseph Shatzel STUDY00018976 A Phase II study of Xisomab 3G3, a monoclonal antibody preventing the activation of FXI by FXIIa, for the prophylaxis of catheter-associated thrombosis.

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080